When a medical device company decides to sell internationally, the first instinct is usually to translate the website and add a currency selector. That is the easy part. The hard part is everything else: regulatory documentation that varies by jurisdiction, product classifications that differ across markets, distributor pricing structures that change by region, and compliance requirements that must be enforced per-market. International medical device commerce is a platform architecture problem, not a translation task.
Regulatory documentation varies by market
A medical device sold in the UK carries UKCA marking. The same device sold in the EU carries CE marking under the Medical Device Regulation. Sold in the US, it requires FDA clearance documentation. Each market has its own regulatory framework, and the product pages must reflect this accurately for the market the buyer is in.
This is not a content translation problem. It is a data architecture problem. The platform must associate the correct regulatory documentation, classification data, and conformity declarations with each product for each market. A UK buyer must see UKCA data. A German buyer must see CE data and MDR compliance information. Showing the wrong regulatory information is not just unhelpful – it can be a compliance violation.
Product names and classifications differ
Medical devices are not always called the same thing across markets. Product names, clinical descriptions, and classification categories can vary between jurisdictions. A device classified as Class IIa under MDR may have a different risk classification under the FDA system. The platform must handle these differences without creating a maintenance nightmare – ideally from a single product record that surfaces the correct market-specific data based on the buyer's location.
Pricing is more than currency conversion
Converting prices between currencies is straightforward. Managing regional pricing is not. A medical device manufacturer may sell at different price points in different markets, reflecting local competitive conditions, distributor margins, regulatory costs, and tax structures. Contract pricing for institutional buyers adds another layer – an NHS trust in the UK may have a negotiated rate that bears no relationship to the list price shown to a hospital in Germany.
The platform must support market-specific pricing that goes beyond simple exchange rate multiplication. It must handle different tax regimes, different price lists per region, and account-specific overrides within each market. The pricing engine needs to evaluate market, customer segment, account, and contract terms to arrive at the correct price for every transaction.
Compliance requirements are market-specific
Data protection rules differ between the UK (UK GDPR) and the EU (EU GDPR). Consumer rights legislation varies. Distance selling regulations have different requirements in different jurisdictions. The platform must enforce the correct compliance rules for each market – different cookie consent flows, different returns policies, different data processing agreements.
For medical devices specifically, post-market surveillance obligations and adverse event reporting requirements vary by regulatory authority. The platform may need to capture and route different information depending on where the product is being sold.
Language is the visible layer, not the hard problem
Professional translation is essential. Machine translation is not acceptable for medical device content where clinical accuracy matters and regulatory text must be precise. But translation is the part that most businesses already understand. The harder problem is the infrastructure beneath the translation – the data model that supports per-market regulatory documentation, the pricing engine that handles regional complexity, the compliance framework that adapts to each jurisdiction.
Architecture before expansion
The most common mistake we see is treating international expansion as a front-end project – translate the pages, add the currencies, launch. The businesses that succeed internationally are the ones that invest in the platform architecture first. They build a data model that supports per-market variation. They design pricing systems that can handle regional complexity. They implement compliance frameworks that adapt automatically.
When the architecture is right, adding a new market becomes a configuration exercise rather than a rebuild. When it is not, every new market multiplies the maintenance burden and the compliance risk. For medical device companies, where the cost of getting compliance wrong is significant, the architecture investment pays for itself quickly.